Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

SIX:SANN.SW

Overview | Financials
Company Name Santhera Pharmaceuticals Holding AG
Symbol SANN.SW
Currency CHF
Price 9.5
Market Cap 107,537,464
Dividend Yield 0%
52-week-range 7.14 - 14.62
Industry Biotechnology
Sector Healthcare
CEO Dr. Thomas Meier Ph.D.
Website https://www.santhera.com

An error occurred while fetching data.

About Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy

Related Stocks

Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A.

NWRN.SW

10.72 CHF

Kuros Biosciences AG logo

Kuros Biosciences AG

KURN.SW

11.4 CHF

Evolva Holding SA logo

Evolva Holding SA

EVE.SW

0.97 CHF

Molecular Partners AG logo

Molecular Partners AG

MOLN.SW

9 CHF

Relief Therapeutics Holding AG logo

Relief Therapeutics Holding AG

RLF.SW

1.11 CHF

Financials

Numbers are in millions USD

Numbers are in millions USD